A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults

Phase 1 Not yet recruiting 8 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the present trial is to obtain information on the absorption, distribution, metabolism, excretion and pharmacokinetics (PK) of 14C-SEP-380135 and its metabolites following a single oral dose.

Timeline

Start: 2026-03-20
Primary completion: 2026-04-10
Completion: 2026-05-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	SEP-380135	Unknown	—	Oral

A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults

Summary

Timeline

Drugs

Indications